Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis, Reviews in Medical Virology, vol.18, issue.Suppl 2, pp.221-261, 2013. ,
DOI : 10.1002/rmv.1739
Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection, Antiviral Research, vol.102, pp.70-86, 2014. ,
DOI : 10.1016/j.antiviral.2013.12.001
Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village, Retrovirology, vol.7, issue.1, p.46, 2010. ,
DOI : 10.1186/1742-4690-7-46
Inhibition of HIV-1 Disease Progression by Contemporaneous HIV-2 Infection, New England Journal of Medicine, vol.367, issue.3, pp.224-256, 2012. ,
DOI : 10.1056/NEJMoa1113244
Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort, AIDS, vol.25, issue.6, pp.865-872, 2011. ,
DOI : 10.1097/QAD.0b013e328344892e
Direct Evidence of Lower Viral Replication Rates In Vivo in Human Immunodeficiency Virus Type 2 (HIV-2) Infection than in HIV-1 Infection, Journal of Virology, vol.81, issue.10, pp.5325-5355, 2007. ,
DOI : 10.1128/JVI.02625-06
Lower Human Immunodeficiency Virus (HIV) Type 2 Viral Load Reflects the Difference in Pathogenicity of HIV???1 and HIV???2, The Journal of Infectious Diseases, vol.180, issue.4, pp.1116-1137, 1999. ,
DOI : 10.1086/315010
Differences in proviral DNA load between HIV-1-infected and HIV-2-infected patients, AIDS, vol.22, issue.11, pp.1379-80, 2008. ,
DOI : 10.1097/QAD.0b013e328303496d
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648216
Differences in proviral DNA load between HIV-1- and HIV-2-infected patients, AIDS, vol.22, issue.2, pp.211-216, 2008. ,
DOI : 10.1097/QAD.0b013e3282f42429
Microglobulin Concentration and Disease Evolution, The Journal of Infectious Diseases, vol.181, issue.1, pp.64-75, 2000. ,
DOI : 10.1086/315170
Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression, Clinical Infectious Diseases, vol.55, issue.10, pp.1417-1442, 2012. ,
DOI : 10.1093/cid/cis708
Direct Relationship between Virus Load and Systemic Immune Activation in HIV???2 Infection, The Journal of Infectious Diseases, vol.201, issue.1, pp.114-136, 2010. ,
DOI : 10.1086/648733
Monocyte and Myeloid Dendritic Cell Activation Occurs Throughout HIV Type 2 Infection, an Attenuated Form of HIV Disease, Journal of Infectious Diseases, vol.207, issue.11, pp.1730-1772, 2013. ,
DOI : 10.1093/infdis/jit085
The protective effect of HIV-2 infection, AIDS, vol.28, issue.7, pp.1065-1072, 2014. ,
DOI : 10.1097/QAD.0000000000000209
Effect of HIV-2 infection on HIV-1 disease progression and mortality, AIDS, vol.28, issue.4, pp.614-619, 2014. ,
DOI : 10.1097/QAD.0000000000000142
Comparison of Heterologous Neutralizing Antibody Responses of Human Immunodeficiency Virus Type 1 (HIV-1)- and HIV-2-Infected Senegalese Patients: Distinct Patterns of Breadth and Magnitude Distinguish HIV-1 and HIV-2 Infections, Journal of Virology, vol.81, issue.10, pp.5331-5339, 2007. ,
DOI : 10.1128/JVI.02789-06
Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation, Journal of General Virology, vol.86, issue.12, pp.3385-96, 2005. ,
DOI : 10.1099/vir.0.81259-0
Epitope Mapping of Broadly Neutralizing HIV-2 Human Monoclonal Antibodies, Journal of Virology, vol.86, issue.22, pp.12115-12143, 2012. ,
DOI : 10.1128/JVI.01632-12
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486499
Broad and Potent Neutralizing Antibody Responses Elicited in Natural HIV-2 Infection, Journal of Virology, vol.86, issue.2, pp.947-60, 2012. ,
DOI : 10.1128/JVI.06155-11
HIV-2 and T cell recognition, Current Opinion in Immunology, vol.10, issue.4, pp.382-389, 1998. ,
DOI : 10.1016/S0952-7915(98)80108-8
Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection, The Journal of Immunology, vol.176, issue.11, pp.6973-81, 2006. ,
DOI : 10.4049/jimmunol.176.11.6973
Polyfunctional T cell responses are a hallmark of HIV-2 infection, European Journal of Immunology, vol.313, issue.2, pp.350-63, 2008. ,
DOI : 10.1002/eji.200737768
Evidence for a Different Susceptibility of Primate Lentiviruses to Type I Interferons, Journal of Virology, vol.87, issue.5, pp.2587-96, 2013. ,
DOI : 10.1128/JVI.02553-12
URL : https://hal.archives-ouvertes.fr/hal-00965877
Differential Restriction of Human Immunodeficiency Virus Type 2 and Simian Immunodeficiency Virus SIVmac by TRIM5?? Alleles, Journal of Virology, vol.79, issue.18, pp.11580-11587, 2005. ,
DOI : 10.1128/JVI.79.18.11580-11587.2005
HIV-2 capsids distinguish high and low virus load patients in a West African community cohort, Vaccine, vol.28, issue.2, pp.60-67, 2010. ,
DOI : 10.1016/j.vaccine.2009.08.060
Cellular entry via an actin and clathrin-dependent route is required for Lv2 restriction of HIV-2, Virology, vol.415, issue.1, pp.47-55, 2011. ,
DOI : 10.1016/j.virol.2011.04.001
An Envelope-Determined, pH-Independent Endocytic Route of Viral Entry Determines the Susceptibility of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 to Lv2 Restriction, Journal of Virology, vol.79, issue.15, pp.9410-9418, 2005. ,
DOI : 10.1128/JVI.79.15.9410-9418.2005
The Antiviral Activities of Tetherin, Curr Top Microbiol Immunol, vol.371, pp.67-104, 2013. ,
DOI : 10.1007/978-3-642-37765-5_3
Emerging Role of the Host Restriction Factor Tetherin in Viral Immune Sensing, Journal of Molecular Biology, vol.425, issue.24, pp.4956-64, 2013. ,
DOI : 10.1016/j.jmb.2013.09.029
Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses, Retrovirology, vol.11, issue.3, 2014. ,
DOI : 10.1186/1742-4690-11-3
URL : http://doi.org/10.1186/1742-4690-11-3
SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells, Retrovirology, vol.9, issue.1, p.87, 2012. ,
DOI : 10.1002/humu.22087
URL : https://hal.archives-ouvertes.fr/pasteur-00750469
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx, Nature, vol.38, issue.7353, pp.654-661, 2011. ,
DOI : 10.1038/nature10117
URL : https://hal.archives-ouvertes.fr/hal-00616451
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates, Nature Immunology, vol.69, issue.3, pp.223-231, 2012. ,
DOI : 10.1006/viro.1995.1016
URL : https://hal.archives-ouvertes.fr/hal-00675672
Restricting HIV the SAMHD1 way: through nucleotide starvation, Nature Reviews Microbiology, vol.16, issue.10, pp.675-80, 2012. ,
DOI : 10.1038/nrmicro2862
URL : https://hal.archives-ouvertes.fr/pasteur-01110079
SAMHD1 Restricts HIV-1 Cell-to-Cell Transmission and Limits Immune Detection in Monocyte-Derived Dendritic Cells, Journal of Virology, vol.87, issue.5, pp.2846-56, 2013. ,
DOI : 10.1128/JVI.02514-12
URL : https://hal.archives-ouvertes.fr/pasteur-01109474
SAMHD1 restricts HIV-1 infection in resting CD4+ T cells, Nature Medicine, vol.9, issue.11, pp.1682-1689, 2012. ,
DOI : 10.1182/blood-2002-07-2224
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction, Nature Medicine, vol.4, issue.8, pp.936-977, 2014. ,
DOI : 10.1038/nmeth.1923
Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell reports, pp.1036-1079, 2013. ,
The Retroviral Restriction Ability of SAMHD1, but Not Its Deoxynucleotide Triphosphohydrolase Activity, Is Regulated by Phosphorylation, Cell Host & Microbe, vol.13, issue.4, pp.441-51, 2013. ,
DOI : 10.1016/j.chom.2013.03.005
Restriction of Virus Infection but Not Catalytic dNTPase Activity Is Regulated by Phosphorylation of SAMHD1, Journal of Virology, vol.87, issue.21, pp.11516-11540, 2013. ,
DOI : 10.1128/JVI.01642-13
The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals, Retrovirology, vol.10, issue.1, p.27, 2013. ,
DOI : 10.1128/JVI.06856-11
The Capsids of HIV-1 and HIV-2 Determine Immune Detection of the Viral cDNA by the Innate Sensor cGAS in Dendritic Cells, Immunity, vol.39, issue.6, pp.1132-1174, 2013. ,
DOI : 10.1016/j.immuni.2013.11.002
URL : https://hal.archives-ouvertes.fr/inserm-00959028
HIV Interplay with SAMHD1, Science, vol.335, issue.6074, pp.1313-1317, 2012. ,
DOI : 10.1126/science.1221057
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells, Nature, vol.78, issue.7312, pp.214-221, 2010. ,
DOI : 10.1038/nature09337
Hiding in Plain Sight: How HIV Evades Innate Immune Responses, Cell, vol.147, issue.2, pp.271-275, 2011. ,
DOI : 10.1016/j.cell.2011.09.010
HIV-2 Vpx Protein Interacts with Interferon Regulatory Factor 5 (IRF5) and Inhibits Its Function, Journal of Biological Chemistry, vol.289, issue.13, pp.9146-57, 2014. ,
DOI : 10.1074/jbc.M113.534321
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979364
Human immunodeficiency virus types 1 and 2 have different replication kinetics in human primary macrophage culture, Journal of General Virology, vol.87, issue.2, pp.411-419, 2006. ,
DOI : 10.1099/vir.0.81391-0
HIV-1 and HIV-2 Differentially Mature Plasmacytoid Dendritic Cells into IFN-Producing Cells or APCs, The Journal of Immunology, vol.193, issue.7, pp.3538-3586, 2014. ,
DOI : 10.4049/jimmunol.1400860
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822683
VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes, EMBO J, vol.8, issue.4, pp.1169-75, 1989. ,
Human Immunodeficiency Virus Vpx Is Required for the Early Phase of Replication in Peripheral Blood Mononuclear Cells, Microbiology and Immunology, vol.335, issue.11, pp.871-879, 1994. ,
DOI : 10.1111/j.1348-0421.1994.tb02140.x
The Human Immunodeficiency Virus Type 2 Vpx Protein Usurps the CUL4A-DDB1DCAF1 Ubiquitin Ligase To Overcome a Postentry Block in Macrophage Infection, Journal of Virology, vol.83, issue.10, pp.4854-60, 2009. ,
DOI : 10.1128/JVI.00187-09
Dendritic Cells Are Less Susceptible to Human Immunodeficiency Virus Type 2 (HIV-2) Infection than to HIV-1 Infection, Journal of Virology, vol.81, issue.24, pp.13486-98, 2007. ,
DOI : 10.1128/JVI.00976-07
Human MxA Protein: An Interferon-Induced Dynamin-Like GTPase with Broad Antiviral Activity, Journal of Interferon & Cytokine Research, vol.31, issue.1, pp.79-87, 2011. ,
DOI : 10.1089/jir.2010.0076
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes, Nature Biotechnology, vol.20, issue.11, pp.1151-1155, 2002. ,
DOI : 10.1038/nbt745
Role of HIV-2 envelope in Lv2-mediated restriction, Virology, vol.332, issue.1, pp.347-58, 2005. ,
DOI : 10.1016/j.virol.2004.11.025
HIV-1 and HIV-2 produce different amounts of 2-long terminal repeat circular DNA in vitro, AIDS, vol.22, issue.18, pp.2543-2548, 2008. ,
DOI : 10.1097/QAD.0b013e328319edab
The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages, Journal of Experimental Medicine, vol.179, issue.1, pp.101-114, 1994. ,
DOI : 10.1084/jem.179.1.101
The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes, Journal of Experimental Medicine, vol.179, issue.1, pp.115-138, 1994. ,
DOI : 10.1084/jem.179.1.115
Anti-HIV Host Factor SAMHD1 Regulates Viral Sensitivity to Nucleoside Reverse Transcriptase Inhibitors via Modulation of Cellular Deoxyribonucleoside Triphosphate (dNTP) Levels, Journal of Biological Chemistry, vol.288, issue.28, pp.20683-91, 2013. ,
DOI : 10.1074/jbc.M113.472159
Cellular and Biochemical Mechanisms of the Retroviral Restriction Factor SAMHD1. ISRN biochemistry, p.728392, 2013. ,
HIV-1 and HIV-2 Reverse Transcriptases: Different Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors, Journal of Virology, vol.86, issue.10, pp.5885-94, 2012. ,
DOI : 10.1128/JVI.06597-11
The Promiscuous CC Chemokine Receptor D6 Is a Functional Coreceptor for Primary Isolates of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 on Astrocytes, Journal of Virology, vol.79, issue.15, pp.9618-9642, 2005. ,
DOI : 10.1128/JVI.79.15.9618-9624.2005
Cross-presentation by human dendritic cell subsets, Immunology Letters, vol.158, issue.1-2, pp.73-81, 2013. ,
DOI : 10.1016/j.imlet.2013.12.001
Cyclic GMP-AMP Synthase Is an Innate Immune Sensor of HIV and Other Retroviruses, Science, vol.341, issue.6148, pp.903-909, 2013. ,
DOI : 10.1126/science.1240933
Tissue Myeloid Cells in SIV-Infected Primates Acquire Viral DNA through Phagocytosis of Infected T Cells, Immunity, vol.41, issue.3, pp.493-502, 2014. ,
DOI : 10.1016/j.immuni.2014.08.014
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro, Journal of Antimicrobial Chemotherapy, vol.62, issue.5 ,
DOI : 10.1093/jac/dkn335
Isolation of a new human retrovirus from West African patients with AIDS, Science, vol.233, issue.4761, pp.343-349, 1986. ,
DOI : 10.1126/science.2425430
Molecular Determinants of HIV-2 R5-X4 Tropism in the V3 Loop: Development of a New Genotypic Tool, Journal of Infectious Diseases, vol.205, issue.1, pp.111-131, 2012. ,
DOI : 10.1093/infdis/jir698
With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIVMAC, Gene Therapy, vol.77, issue.12, pp.991-995, 2006. ,
DOI : 10.1038/sj.gt.3302753
Innate Sensing of HIV-Infected Cells, PLoS Pathogens, vol.178, issue.2, p.1001284, 2011. ,
DOI : 10.1371/journal.ppat.1001284.s002
URL : https://hal.archives-ouvertes.fr/pasteur-00590930
New Sensitive One-Step Real-Time Duplex PCR Method for Group A and B HIV-2 RNA Load, Journal of Clinical Microbiology, vol.52, issue.8, pp.3017-3039, 2014. ,
DOI : 10.1128/JCM.00724-14